According to the latest report by IMARC Group, titled “Drug Abuse Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global drug abuse testing market size reached US$ 6.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.2 Billion by 2027, exhibiting a growth rate (CAGR) of 7.2% during 2022-2027.
Drug abuse refers to the deliberate consumption of illegal substances or the overconsumption of prescribed psychoactive and over-the-counter (OTC) medications. It can affect the mind and body and cause several disorders, including addiction. As a result, drug abuse is diagnosed by using numerous testing methods to treat related problems effectively. Drug abuse testing also aids in managing the mental status of a patient, handling seizure cases in the emergency room, identifying children and newborns at risk of exposure to illicit drugs, etc. It also finds extensive applications in workplaces where job applicants can be tested for drug usage before being hired.
Request for a free sample copy of this report: https://www.imarcgroup.com/drug-abuse-testing-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The growing drug dependency and substance abuse among individuals for their mind-altering characteristics, medical, non-therapeutic and medicinal uses, and other purposes, such as weight loss, enhancing athletic performance, etc., are primarily driving the drug abuse testing market across the globe. In addition to this, the rising awareness about the harmful consequences of drug abuse, which can create prominent safety and health hazards and reduce the productivity and morale of an individual, is further propelling the product demand. Besides this, the escalating need for screening of employees and job applicants for providing a safe workplace and complying with stringent laws and regulations passed by government bodies is acting as another growth-inducing factor. Additionally, the improving technologies utilized by pain management and opioid dependency clinics are fueling the demand for urine drug testing, which is catalyzing the market growth. Moreover, the emergence of automated testing and analysis for drugs of abuse with at-home testing kits is projected to drive the global drug abuse testing market over the forecasted period.
Breakup by Product:
- Immunoassays Analyzers
- Chromatographic Devices
- Breath Analyzers
- Rapid Testing Devices
- Urine Testing Devices
- Oral Fluid Testing Devices
- Laboratory Services
Breakup by Sample:
- Oral Fluid (Saliva)
Breakup by End User:
- Diagnostic Laboratories
- Forensic Laboratories
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Abbott Laboratories
- Bio-Rad Laboratories Inc
- Danaher Corporation
- Drägerwerk AG & Co. KGaA
- F. Hoffmann-La Roche AG
- Laboratory Corporation of America Holdings
- Omega Laboratories Inc
- Quest Diagnostics Incorporated
- Siemens AG
- Thermo Fisher Scientific Inc
- United States Drug Testing Laboratories Inc
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/drug-abuse-testing-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800